2016
DOI: 10.1242/jcs.183889
|View full text |Cite
|
Sign up to set email alerts
|

PAX5 interacts with RIP2 to promote NF-κB activation and drug-resistance of B-lymphoproliferative disorders

Abstract: Paired box protein 5 (PAX5) plays a lineage determination role in B-cell development. However, high expression of PAX5 has been also found in various malignant diseases, including B-lymphoproliferative disorders (B-LPDs), but its functions and mechanisms in these diseases are still unclear. Here, we show that PAX5 induces drug resistance through association and activation of receptor-interacting serine/threonine-protein kinase 2 (RIP2; also known as RIPK2), and subsequent activation of NF-κB signaling and anti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
15
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(17 citation statements)
references
References 47 publications
2
15
0
Order By: Relevance
“…3 b). Moreover, it is noting that cisplatin resistance by the high expression of IKKα and further affecting up-regulation expression of NF-κB, not IKKβ which IKKβ is considered as classic path way to activate NF-κB [ 16 ].…”
Section: Resultsmentioning
confidence: 99%
“…3 b). Moreover, it is noting that cisplatin resistance by the high expression of IKKα and further affecting up-regulation expression of NF-κB, not IKKβ which IKKβ is considered as classic path way to activate NF-κB [ 16 ].…”
Section: Resultsmentioning
confidence: 99%
“…Real et al proposed that upregulation of CCND2 is involved in the protection against Gamma‐secretase inhibitors (GSIs), which are Notch pathway inhibitors used in GC‐resistant T‐cell acute lymphoblastic leukemia (T‐ALL) . Additionally, reliability of the top enriched pathway associated with GC resistance, Transcriptional misregulation in cancer, is further supported by studies reporting that BCL2A1, PAX5, and CXCL8 play important roles in GC‐resistant ALL . Moreover, Pathways in cancer (map05200 on KEGG website) comprised various oncogenesis signaling pathways including MAPK, JAT/STAT, and PI3K‐AKT signaling pathways, which were confirmed to promote development of GC resistance in leukemia by multiple independent studies .…”
Section: Discussionmentioning
confidence: 99%
“…The genes with differentially methylated CpG’s in their promoters were used to identify relevant transcription factors, and several such identified factors have known prominent roles in inflammation, including PAX5, AP4, CREB, IRF2 and XBP1. PAX5 is a transcription factor that regulates various B cell functions including activation of NF-kB [21]. IRF2 (Interferon regulatory factor 2) regulates IFN-β expression and was found to inhibit LPS induced proinflammatory responses [22].…”
Section: Discussionmentioning
confidence: 99%